Le Magueresse-Battistoni Brigitte, Vidal Hubert, Naville Danielle
Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition, CarMeN, université Lyon 1, Inserm U1060, UMR Inra 1397, Insa-Lyon, faculté de médecine Lyon-sud-BP12, 165, chemin du Grand Revoyet, 69921 Oullins Cedex, France.
Med Sci (Paris). 2016 Jan;32(1):51-6. doi: 10.1051/medsci/20163201009. Epub 2016 Feb 5.
Obesity is a major public health problem because it is a risk factor for metabolic disorders including type 2 diabetes and cardiovascular disorders. Notably, pollutants endowed with endocrine disrupting activities have been charged to contribute to the etiology of obesity and type 2 diabetes, especially if exposure occurs during the early life shown to be a highly vulnerable window of time. An overview on endocrine disrupters in relation with the obesogen and metabolic disruption hypothesis is presented. Convincing data support the plausibility of such hypothesis. They also highlight the limits of the current threshold model used in risk assessment which focused on single chemicals and does not take into account potential effects of mixtures containing pollutants at environmental doses, e.g. the real life exposure. Certainly, the principle of precaution should guide the making of decisions especially when considering early life exposure.
肥胖是一个主要的公共卫生问题,因为它是包括2型糖尿病和心血管疾病在内的代谢紊乱的危险因素。值得注意的是,具有内分泌干扰活性的污染物被认为与肥胖和2型糖尿病的病因有关,特别是如果在生命早期发生暴露,而生命早期被证明是一个高度脆弱的时期。本文对与肥胖诱导物和代谢紊乱假说相关的内分泌干扰物进行了综述。有说服力的数据支持了这一假说的合理性。这些数据还突出了当前风险评估中使用的阈值模型的局限性,该模型侧重于单一化学品,没有考虑环境剂量下含有污染物的混合物的潜在影响,例如实际生活中的暴露。当然,预防原则应该指导决策的制定,尤其是在考虑生命早期暴露时。